These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29510947)

  • 1. A combination of
    Nagatoishi S; Yamaguchi S; Katoh E; Kajita K; Yokotagawa T; Kanai S; Furuya T; Tsumoto K
    Bioorg Med Chem; 2018 May; 26(8):1929-1938. PubMed ID: 29510947
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and generation of highly diverse fluorinated fragment libraries and their efficient screening with improved (19) F NMR methodology.
    Vulpetti A; Dalvit C
    ChemMedChem; 2013 Dec; 8(12):2057-69. PubMed ID: 24127294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided screening strategy combining surface plasmon resonance with nuclear magnetic resonance for identification of small-molecule Argonaute 2 inhibitors.
    Harumoto T; Sato A; Takayama Y; Miyagi H; Saito JI; Shinohara F
    PLoS One; 2020; 15(7):e0236710. PubMed ID: 32735606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of B. anthracis N(5)-carboxyaminoimidazole ribonucleotide mutase (PurE) active site binding compounds via fragment library screening.
    Lei H; Jones C; Zhu T; Patel K; Wolf NM; Fung LW; Lee H; Johnson ME
    Bioorg Med Chem; 2016 Feb; 24(4):596-605. PubMed ID: 26740153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Characterization of a Cryptic Secondary Binding Site in the Molecular Chaperone HSP70.
    O'Connor S; Le Bihan YV; Westwood IM; Liu M; Mak OW; Zazeri G; Povinelli APR; Jones AM; van Montfort R; Reynisson J; Collins I
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hit-to-Lead: Hit Validation and Assessment.
    Hevener KE; Pesavento R; Ren J; Lee H; Ratia K; Johnson ME
    Methods Enzymol; 2018; 610():265-309. PubMed ID: 30390802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and characterization of a substrate selective p38alpha inhibitor.
    Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
    Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPR-based fragment screening: advantages and applications.
    Neumann T; Junker HD; Schmidt K; Sekul R
    Curr Top Med Chem; 2007; 7(16):1630-42. PubMed ID: 17979772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling.
    Lee H; Ren J; Pesavento RP; Ojeda I; Rice AJ; Lv H; Kwon Y; Johnson ME
    Bioorg Med Chem; 2019 May; 27(10):1981-1989. PubMed ID: 30940566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of fragment screening methods on the p38α kinase: new methods, new insights.
    Pollack SJ; Beyer KS; Lock C; Müller I; Sheppard D; Lipkin M; Hardick D; Blurton P; Leonard PM; Hubbard PA; Todd D; Richardson CM; Ahrens T; Baader M; Hafenbradl DO; Hilyard K; Bürli RW
    J Comput Aided Mol Des; 2011 Jul; 25(7):677-87. PubMed ID: 21732248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
    Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
    J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biophysical Analysis of the Protein-Small Molecule Interactions to Develop Small Molecule Drug Discovery].
    Nagatoishi S; Caaveiro JMM; Tsumoto K
    Yakugaku Zasshi; 2018; 138(8):1033-1041. PubMed ID: 30068844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
    ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 3F Library: Fluorinated Fsp
    Troelsen NS; Shanina E; Gonzalez-Romero D; Danková D; Jensen ISA; Śniady KJ; Nami F; Zhang H; Rademacher C; Cuenda A; Gotfredsen CH; Clausen MH
    Angew Chem Int Ed Engl; 2020 Feb; 59(6):2204-2210. PubMed ID: 31724281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Straightforward hit identification approach in fragment-based discovery of bromodomain-containing protein 4 (BRD4) inhibitors.
    Borysko P; Moroz YS; Vasylchenko OV; Hurmach VV; Starodubtseva A; Stefanishena N; Nesteruk K; Zozulya S; Kondratov IS; Grygorenko OO
    Bioorg Med Chem; 2018 Jul; 26(12):3399-3405. PubMed ID: 29764756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragment based drug discovery: practical implementation based on ¹⁹F NMR spectroscopy.
    Jordan JB; Poppe L; Xia X; Cheng AC; Sun Y; Michelsen K; Eastwood H; Schnier PD; Nixey T; Zhong W
    J Med Chem; 2012 Jan; 55(2):678-87. PubMed ID: 22165820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-Linking Approach Using (19)F NMR Spectroscopy To Obtain Highly Potent and Selective Inhibitors of β-Secretase.
    Jordan JB; Whittington DA; Bartberger MD; Sickmier EA; Chen K; Cheng Y; Judd T
    J Med Chem; 2016 Apr; 59(8):3732-49. PubMed ID: 26978477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.
    Silvestre HL; Blundell TL; Abell C; Ciulli A
    Proc Natl Acad Sci U S A; 2013 Aug; 110(32):12984-9. PubMed ID: 23872845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.